anti-CD7 nanobody based immunotoxins (Soochow University/PersonGen Biomedicine)

N/A

Report date: 2025/03/14 16:48:20

Base Information

Drug Nameanti-CD7 nanobody based immunotoxins (Soochow University/PersonGen Biomedicine)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionT-cell antigen CD7 modulators
TargetsT-cell antigen CD7
Therapy Area/IndicationsPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSoochow University
China Registration ClassN/A

Develop Information

Active CompaniesSoochow UniversityPersongen Biotherapeutics (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A